Hepatitis B surface antigen (HBsAg) prevalence (%) in Indonesia
Indonesia: Hepatitis B surface antigen (HBsAg) prevalence was 0.7% in 2024. ▼ Falling
Latest (2024)
0.7%
Change on year
down 12.5%
World rank
43rd
of 194 countries
All-time high
1.0%
in 2015
All-time low
0.7%
in 2024
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Indonesia, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Indonesia is 0.7%, measured in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 12.5% on the previous year and down 30.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Indonesia peaked at 1.0% in 2015 and was at its lowest, 0.7%, in 2024.
That places Indonesia 43rd out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.0% | — |
| 2016 | 0.9% | -10.0% |
| 2017 | 0.9% | +0.0% |
| 2018 | 0.9% | +0.0% |
| 2019 | 0.8% | -11.1% |
| 2020 | 0.9% | +12.5% |
| 2021 | 0.9% | +0.0% |
| 2022 | 0.9% | +0.0% |
| 2023 | 0.8% | -11.1% |
| 2024 | 0.7% | -12.5% |
Indonesia compared with similar countries
- Indonesia's 0.7% is above the median for upper middle income countries, which is 0.2%, 3.5× the median. (57 countries reporting)
- Indonesia's 0.7% is above the median for East Asia & Pacific, which is 0.6%, 1.2× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.9% | 0.8% | 1.0% | 5 |
| 2020s | 0.8% | 0.7% | 0.9% | 5 |
Countries ranked near Indonesia
- 43 Sierra Leone 0.7% compare
- 43 Benin 0.7% compare
- 43 Burkina Faso 0.7% compare
- 43 Brunei 0.7% compare
- 43 Cape Verde 0.7% compare
- 43 Kenya 0.7% compare
- 43 Liberia 0.7% compare
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Indonesia?
- Hepatitis b surface antigen (hbsag) prevalence in Indonesia was 0.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Indonesia?
- The highest recorded value was 1.0% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Indonesia?
- The lowest recorded value was 0.7% in 2024.
- How does Indonesia rank for hepatitis b surface antigen (hbsag) prevalence?
- Indonesia ranks 43rd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Indonesia?
- Over the last ten years it is down 30.0%. The long-run trend across the full record is falling.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).